Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
115.1 EUR | -1.37% | -2.12% | -12.46% |
07:23am | REDCARE PHARMACY : UBS gives a Sell rating | ZD |
Jun. 06 | REDCARE PHARMACY : Berenberg gives a Buy rating | ZD |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The company appears highly valued given the size of its balance sheet.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.32% | 2.57B | B | ||
-39.33% | 13.67B | B- | ||
-8.96% | 7.95B | B | ||
+4.90% | 5.86B | C | ||
-14.08% | 5.71B | C+ | ||
-3.07% | 4.6B | D- | ||
+70.58% | 4.5B | C | ||
-8.29% | 3.77B | B | ||
-22.05% | 3.05B | C- | ||
-12.88% | 2.81B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- RDC Stock
- Ratings Redcare Pharmacy NV